Controversial relationship between the expression of the RB pathway components and RB protein phosphorylation in human breast cancer

Histology and Histopathology

Volumn 22, Issue 7-9, 2007, Pages 769-775

  Montanaro, L ^a   Vici, M ^a   Donati, G ^a   Ceccarelli, C ^b   Santini, D ^b   Trere D ^a   Derenzini, Massimo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Breast cancer; Cell cycle; Immunohistochemistry; RB; Real time RT PCR

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN E; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN P16INK4A; PROTEIN P27; RETINOBLASTOMA PROTEIN; CDK4 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN D; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; ESTROGEN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; BREAST CARCINOMA; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BREAST TUMOR; CHEMISTRY; COMPARATIVE STUDY; FEMALE; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CYCLIN E; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; PHOSPHORYLATION; RECEPTORS, ESTROGEN; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34248550780     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Alkarain A. and Slingerland J. (2004). Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer. Breast Cancer Res. 6, 13-21.
2. An H-X., Beckmann M.W., Reifenberger G., Bender HG. and Niederacher D. (1999). Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation. Am. J. Pathol. 154, 113-118.
3. Arnold A. and Papanikolaou A. (2005). Cyclin D1 in breast cancer pathogenesis. J. Clin. Oncol. 23, 4215-4224.
4. Caldon C.E., Daly R.J., Sutherland R.L. and Musgrove E.A. (2006). Cell cycle control in breast cancer cells. J. Cell. Biochem. 97, 261-274.
5. Coqueret O. (2002). Linking cyclins to transcriptional control. Gone 299, 35-55.
6. Elston C.W. and Ellis I.O. (1991). Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 19, 403-410.
7. Erber R., Klein W., Andl T., Enders C., Born A.I., Conradt C., Bartek J. and Bosch FX (1997). Aberrant p21(CIP1/WAF1) protein accumulation in head-and-neck cancer. Int. J. Cancer 74, 383-389.
8. Ewen M.E. and Lamb J. (2004). The activities of cyclin D1 that drive tumorigenesis. Trends Mol. Med. 10, 158-162.
9. Faccioli S., Chieco P., Gramantieri L., Stecca B. and Bolondi L. (1996). Cytometric measurement of cell proliferation in echo-guided biopsies from focal lesions of the liver. Mod. Pathol. 9, 120-125.
10. Han S., Park K., Bea B.N., Kim K.H., Kim H.J., Kim Y.D. and Kim H.Y. (2003). Prognostic implication of cyclin E expression and its relationship with cyclin D1 and p27Kip1 expression on tissue microarrays of node negative breast cancer. J. Surg. Oncol. 83, 241-247.
11. Harbour J.W. and Dean D.C. (2000). The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14, 2393-2409.
12. Hui R., Cornish A.L., McClelland R.A., Robertson J.F., Blamey R.W., Musgrove E.A., Nicholson R.I. and Sutherland R.L. (1996). Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. Clin. Cancer Res. 2, 923-928.
13. Hunt K.K. and Keyomarsi K. (2005). Cyclin E as a prognostic and predictive marker in breast cancer. Semin. Cancer Biol. 15, 319-326.
14. Jares P., Rey M.J., Fernandez P.L., Campo E., Nadal A., Munoz M., Mallofre C., Muntane J., Nayach I., Estape J. and Cardesa A. (1997). Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status. J. Pathol. 182, 160-166.
15. Jung J., Bruner J., Ruan S., Langford L., Kyritsis A., Kobayashi T., Levin V. and Zhang W. (1995). Increased levels of p21WAF1/Cip1 in human brain tumors. Oncogene 11, 201-208.
16. Moroy T. and Geisen C. (2004) Cyclin E. Int. J. Biochem. Cell. Biol. 36, 1424-1439.
17. Pardee A.B. (1989). G1 events and regulation of cell proliferation. Science 246, 603-608.
18. Sherr C.J. and McCormick F. (2002). The RB and p53 pathways in cancer. Cancer Cell 2, 103-112
19. Sherr C.J. and Roberts J.M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512.
20. Sutherland R.L. and Musgrove E.A. (2004). Cyclins and breast cancer. J. Mammary Gland Biol. Neoplasia 9, 95-104.
21. Yu Q., Sicinska E., Gang Y., Ahnstrom M., Zagozdzon A., Kong Y., Gardner H., Kiyokawa H., Harris L.N., Stal O. and Sicinski P. (2006). Requirement for CDK4 kinase function in breast cancer. Cancer Cell 9, 23-32.